Last reviewed: June 16, 2026
Last updated: June 16, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, a GLP-1 receptor agonist initially developed for diabetes management, has demonstrated significant weight loss effects in clinical trials, with patients achieving 10–22% body weight reduction over 68 weeks. PlexusDx provides compounded semaglutide injections to Florida patients through licensed 503A pharmacies, offering personalized dosing protocols without the constraints of brand-name pricing or insurance requirements.
How Compounded Semaglutide Works for Weight Loss
Semaglutide functions by activating GLP-1 receptors in the brain and gut, which regulate appetite signaling and blood sugar stability. When these receptors are stimulated, the brain receives stronger satiety signals, reducing hunger drive and caloric intake naturally. The medication also slows gastric emptying, prolonging feelings of fullness after meals and decreasing overall food consumption throughout the day.
The injectable form delivers semaglutide subcutaneously once weekly, allowing steady accumulation in the bloodstream and consistent appetite suppression. Research shows that weekly injection protocols maintain therapeutic levels with fewer fluctuations compared to daily oral dosing. For Florida patients, this consistency translates to more predictable weight loss trajectories and easier adherence to treatment schedules.
Florida Access and Licensing Standards
PlexusDx partners exclusively with licensed 503A compounding pharmacies registered with Florida's Department of Business and Professional Regulation. These facilities operate under strict USP <797> standards for sterile preparation and quality assurance, ensuring every semaglutide injection meets pharmaceutical-grade purity requirements. Unlike 503B outsourcing facilities, 503A compounders maintain state licensure and direct pharmacist oversight of formulation and dispensing.
Florida residents benefit from no insurance requirements, no membership fees, and no state-specific restrictions on compounded GLP-1 access. PlexusDx ships to all 50 states, including Florida, with treatment beginning at $149 monthly for compounded semaglutide injections. The platform also accepts HSA and FSA funds, reducing out-of-pocket costs for eligible patients.
Personalized Dosing Without Price Escalation
PlexusDx employs a unique flat-rate pricing model where monthly costs remain constant regardless of dose adjustments. Patients may start at a lower dose and increase incrementally based on clinical response and tolerability, but the monthly subscription price stays fixed. This approach removes financial barriers to dose optimization—a key factor in achieving sustained weight loss and minimizing side effects through gradual titration.
Typical semaglutide protocols begin at 0.25 mg weekly and increase by 0.25 mg each month until reaching a therapeutic dose of 0.5–1.0 mg weekly. Some patients respond optimally at lower doses, while others require higher amounts for appetite suppression. PlexusDx's flat-rate structure ensures that patients can safely find their effective dose without concern that increasing to a higher strength will trigger a price increase.
Precision Peptide Genetic Testing for Optimized Outcomes
The Precision Peptide Genetic Test offered by PlexusDx ($99 add-on after the first month) analyzes 14 metabolic pathways and 49 peptide-related variants to identify individual predispositions affecting GLP-1 response. Key genetic markers include GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313—each influencing appetite regulation, energy expenditure, and medication efficacy. Understanding these genetic factors allows clinicians to tailor semaglutide dosing, timing, and complementary therapies to each patient's unique biology.
Genetic insights also reveal whether a patient may benefit from dual-peptide protocols, such as PlexusDx's GLP-Squared combination (semaglutide plus tirzepatide), or benefit from adjunctive oral medications. Florida patients can request genetic testing during their first month of treatment to unlock personalized guidance for long-term weight loss success and metabolic health optimization.
Safety, Side Effects, and Clinical Expectations
Common side effects of semaglutide include nausea, constipation, and mild headache—typically mild and self-limiting during the first 2–3 weeks of treatment. Gradual dose escalation minimizes gastrointestinal upset, allowing the body to acclimate to appetite suppression. Serious adverse events such as pancreatitis or thyroid complications are rare and occur at comparable rates to those in registered trials; patients with personal or family histories of medullary thyroid cancer should not use semaglutide.
Clinical weight loss begins around week 4–6 of consistent dosing, with most patients experiencing measurable reductions by month 2–3. Sustainable results typically emerge over 4–6 months as appetite suppression deepens and lifestyle changes compound. PlexusDx provides ongoing clinical support to monitor progress, manage side effects, and adjust protocols as needed, ensuring Florida patients achieve their weight loss goals safely and effectively.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I get compounded semaglutide in Florida without insurance?
Yes. PlexusDx requires no insurance, no membership fees, and no prior authorization. Compounded semaglutide injections start at $149 per month and are available to all Florida residents. HSA and FSA funds are accepted to further reduce costs.
What is the difference between compounded semaglutide and brand-name Ozempic or Wegovy?
PlexusDx compounds semaglutide through licensed 503A pharmacies using FDA-approved ingredients, whereas Ozempic and Wegovy are brand-name products manufactured under FDA oversight. Compounded versions offer flexible dosing, lower cost, and no insurance requirement. Both are chemically identical semaglutide but differ in manufacturing oversight and pricing structure.
How does the flat-rate pricing work if my dose increases?
PlexusDx charges a flat monthly rate regardless of your dose strength. You may begin at a lower dose and increase gradually—your price remains $149/month for compounded semaglutide injections. This structure ensures safe, stepwise dose optimization without financial penalties.
What are the most common side effects of semaglutide?
Nausea, constipation, and mild headache are typical early side effects, usually resolving within 2–3 weeks. Slow dose escalation minimizes stomach upset. Serious complications like pancreatitis are rare. PlexusDx clinical staff monitor your response and adjust your protocol to manage any adverse effects.
Should I get the Precision Peptide Genetic Test?
The Precision Peptide Genetic Test ($99 add-on) identifies genetic variants in 14 metabolic pathways that influence GLP-1 response and appetite regulation. Results guide personalized dosing, reveal whether dual-peptide therapy may benefit you, and optimize long-term weight loss strategy—especially valuable for patients who have failed previous weight loss efforts or have complex metabolic profiles.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Can You Take Ozempic with Berberine? Navigating Your Weight Loss Journey
Which is Better: Tirzepatide or Wegovy?